Yu Ling Huang1, Lindsay K Dickerson2, Heidi Kenerson2

  • 1Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, WA, USA.

BME frontiers
|October 18, 2023
PubMed
概括

开发针对个性化瘤学的临床相关平台至关重要. 有希望的器官类型培养方法正在出现,以测试个体的癌症药物敏感性,旨在改善患者的治疗结果.